Exposing 12 myths that support drug price controls and harm our health system
OTTAWA, ON (June 28, 2022): Is the Patented Medicine Prices Review Board (PMPRB) causing more harm than good? A recent ...
OTTAWA, ON (June 28, 2022): Is the Patented Medicine Prices Review Board (PMPRB) causing more harm than good? A recent ...
By Richard C. Owens with Rebecca Rosenberg and Haya Sardar June 28, 2022 PDF of paper Executive Summary Canada’s Patented ...
OTTAWA, ON (June 2, 2022): The PMPRB, a regulatory body formed in 1987, was never a principled policy initiative targeted ...
By Richard C. Owens, Rebecca Rosenberg, and Haya Sardar June 2, 2022 PDF of paper Executive Summary Canada’s drug price ...
By Nigel Rawson and John Adams, May 2, 2022 On April 14, 2022, Health Minister Jean-Yves Duclos announced the federal ...
A new MLI commentary warns that pending and aggressive drug price control efforts could lead to major unintended consequences in ...
The PMPRB has abused its independence. The functional purpose of the PMPRB is no longer relevant, write Nigel Rawson and ...
The federal government is pursuing an aggressive agenda using untried methods to regulate extremely low drug prices, writes Nigel Rawson. ...
Unless Ottawa guarantees the price or postpones the PMPRB revisions, manufacturers will not know whether a tendered price is compliant ...
OTTAWA, ON (June 2, 2020): Changes to the Patented Medicine Prices Review Board (PMPRB) have been delayed until January 2021 ...
323 Chapel Street, Suite #300
Ottawa, Ontario
K1N 7Z2 Canada
613.482.8327
Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.
© 2021 Macdonald-Laurier Institute. All Rights reserved.